Pro-active Genetic Testing in Kidney Transplant Patients

Running, not enrolling

Conditions studied: Kidney Transplant

In brief

The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.

Key facts

Study ID

NCT05298904

Run by

Mayo Clinic

People needed

177

Starts

2022-03-28

Expected to finish

2038-03-01

Last updated by the study team

2026-01-27

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Post transplant Kidney and Kidney Pancreas recipients.

You may not qualify if…

• Simultaneous Liver Kidney Transplant.
• Simultaneous Heart Kidney Transplant.
• Non renal transplant history.

Where it is running

• Mayo Clinic Arizona — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.